<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages>en</availableLanguages>
  <rcn>244224</rcn>
  <id>190152193</id>
  <acronym>PARAGON NOVEL VACCINE</acronym>
  <teaser>Immunethep has developed, patented (WO/2015/189422), and successfully undergone preclinical trials for a new breakthrough vaccine (PNV-Paragon Novel Vaccine). It protects against bacterial infections caused by 5 different bacteria: S. aureus, S. pneumoniae, K. pneumoniae, E...</teaser>
  <objective>Immunethep has developed, patented (WO/2015/189422), and successfully undergone preclinical trials for a new breakthrough vaccine (PNV-Paragon Novel Vaccine). It protects against bacterial infections caused by 5 different bacteria: S. aureus, S. pneumoniae, K. pneumoniae, E. coli and GBS. Our innovation relies on the discovery of a virulence and immunosuppressive mechanism common to these pathogens. The bacteria excrete a highly immunosuppressive protein designated as glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which disables the host immune response to infection. PNV works by blocking bacterial GAPDH, while not reacting to human GAPDH, allowing the host immune system to fight infection and eliminate the bacteria. Preclinical trials demonstrated high levels of efficacy against any of the 5 bacteria with an excellent safety profile. PNV is the worlds first vaccine not only to prevent multiple bacterial infections but for all invasive serotypes, including multi-resistant strains.</objective>
  <title>Paragon Novel Vaccine (PNV) an effective protection against all serotypes of five deadly bacteria to eradicate Antimicrobial Resistance (AMR)</title>
  <totalCost>7400192.5</totalCost>
  <ecMaxContribution>2499999.99</ecMaxContribution>
  <startDate>2023-01-01</startDate>
  <endDate>2025-06-30</endDate>
  <ecSignatureDate>2022-12-21</ecSignatureDate>
  <duration>30</duration>
  <status>SIGNED</status>
  <keywords>Multivalent vaccine for five bacteria (1st worldwide),Preventive immunotherapy for infectious diseases,Antimicrobial Resistance (AMR),Effective against all serotypes (full coverage) ,GAPDH immunosuppressive protein</keywords>
  <identifiers>
    <grantDoi>10.3030/190152193</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>true</euroSciVoc>
  </validation>
  <sourceUpdateDate>2022-12-23 17:02:52</sourceUpdateDate>
  <contentCreationDate>2023-03-07 11:08:38</contentCreationDate>
  <contentUpdateDate>2023-04-05 13:27:35</contentUpdateDate>
  <lastUpdateDate>2025-09-19 14:48:46</lastUpdateDate>
  <relations>
    <associations>
      <article source="editorial" type="relatedArticle">
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <rcn>440864</rcn>
        <id>440864-multipotent-antibacterial-vaccine</id>
        <title>Multipotent antibacterial vaccine</title>
        <contentUpdateDate>2023-07-25 17:58:59</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/projectDescription</code>
              <title>Project description</title>
              <description>Article: description of linked project written by editorial team</description>
              <displayCode>/Project description</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode>/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
      </article>
      <call source="corda" type="relatedMasterCall">
        <rcn>55635</rcn>
        <title>HORIZON-EIC-2022-ACCELERATOR-01</title>
        <identifier>HORIZON-EIC-2022-ACCELERATOR-01</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>55635</rcn>
        <title>HORIZON-EIC-2022-ACCELERATOR-01</title>
        <identifier>HORIZON-EIC-2022-ACCELERATOR-01</identifier>
      </call>
      <organization netEcContribution="2499999.99" totalCost="7400192.5" source="corda" order="1" ecContribution="2499999.99" terminated="false" sme="true" type="coordinator">
        <availableLanguages>en</availableLanguages>
        <rcn>1980941</rcn>
        <id>911201123</id>
        <vatNumber>PT510824439</vatNumber>
        <legalName>IMMUNETHEP</legalName>
        <address>
          <street>BIOCANT PARK, NUCLEO 4 LOTE 3</street>
          <city>Cantanhede</city>
          <postalCode>3060 197</postalCode>
          <country>PT</country>
          <geolocation>40.3654887,-8.658317806596092</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <rcn>1471666</rcn>
              <nutsCode>PT192</nutsCode>
            </region>
            <region type="relatedRegion">
              <name>Portugal</name>
              <rcn>427199016</rcn>
              <nutsCode>PT</nutsCode>
              <euCode>PT</euCode>
              <isoCode>PT</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme type="relatedLegalBasis" source="corda" uniqueProgrammePart="true">
        <availableLanguages>en</availableLanguages>
        <rcn>705792</rcn>
        <id>HORIZON.3.1</id>
        <code>HORIZON.3.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.3.1</pga>
        <title>The European Innovation Council (EIC)</title>
        <parent>
          <programme>
            <rcn>705791</rcn>
            <code>HORIZON.3</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedTopic" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>706909</rcn>
        <id>HORIZON_HORIZON-EIC-2022-ACCELERATOROPEN-01</id>
        <code>HORIZON-EIC-2022-ACCELERATOROPEN-01</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>EIC Accelerator Open</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode>/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43456234</code>
              <title>Project financing</title>
              <displayCode>/Project financing</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43454386</code>
              <title>Market-creating innovation</title>
              <displayCode>/Market-creating innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450539</code>
              <title>Competitor analysis</title>
              <displayCode>/Competitor analysis</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450029</code>
              <title>Business model innovation</title>
              <displayCode>/Business model innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43451698</code>
              <title>Entrepreneurship</title>
              <displayCode>/Entrepreneurship</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43453594</code>
              <title>Innovation support services</title>
              <displayCode>/Innovation support services</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43457773</code>
              <title>Spin-off companies</title>
              <displayCode>/Spin-off companies</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43456213</code>
              <title>Product innovation</title>
              <displayCode>/Product innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43454395</code>
              <title>Marketing strategy</title>
              <displayCode>/Marketing strategy</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43453822</code>
              <title>Investment readiness</title>
              <displayCode>/Investment readiness</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43452043</code>
              <title>Feasibility analysis</title>
              <displayCode>/Feasibility analysis</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43458031</code>
              <title>Sustainable innovation</title>
              <displayCode>/Sustainable innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450041</code>
              <title>Business support services</title>
              <displayCode>/Business support services</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43458163</code>
              <title>Technological innovation</title>
              <displayCode>/Technological innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43457365</code>
              <title>SME support</title>
              <displayCode>/SME support</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43456414</code>
              <title>Public sector innovation</title>
              <displayCode>/Public sector innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43456186</code>
              <title>Private investment</title>
              <displayCode>/Private investment</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43453576</code>
              <title>Innovation management</title>
              <displayCode>/Innovation management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450521</code>
              <title>Company valuation</title>
              <displayCode>/Company valuation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43452100</code>
              <title>Financial &amp; Investment management</title>
              <displayCode>/Financial &amp; Investment management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43451181</code>
              <title>Due diligence</title>
              <displayCode>/Due diligence</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43451088</code>
              <title>Disruptive innovation</title>
              <displayCode>/Disruptive innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43458202</code>
              <title>Technology management</title>
              <displayCode>/Technology management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450026</code>
              <title>Business management</title>
              <displayCode>/Business management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450017</code>
              <title>Business development</title>
              <displayCode>/Business development</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43458661</code>
              <title>Venture capital</title>
              <displayCode>/Venture capital</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450014</code>
              <title>Business coaching and mentoring</title>
              <displayCode>/Business coaching and mentoring</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43456756</code>
              <title>Risk management</title>
              <displayCode>/Risk management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43453837</code>
              <title>IPR management</title>
              <displayCode>/IPR management</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1092442</rcn>
        <id>190152193_PSHORIZON</id>
        <title>Periodic Reporting for period 1 - PARAGON NOVEL VACCINE (Paragon Novel Vaccine (PNV) an effective protection against all serotypes of five deadly bacteria to eradicate Antimicrobial Resistance (AMR))</title>
        <description>periodic</description>
        <teaser>Antimicrobial Resistance (AMR) is leading to an uncontrolled rise of superbugs. This worldwide threat kills around 1.27 million people/year and it is estimated to increase by 8-fold until 2050, surpassing 10 million deaths/year. Today AMR costs around $30 billion/year to...</teaser>
        <sourceUpdateDate>2024-05-10 05:25:32</sourceUpdateDate>
        <contentUpdateDate>2024-05-10 12:38:00</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/pubsum</code>
              <title>Report Summary</title>
              <description>Result: Publishable summary (FP7 SESAM) and Summary for publication (H2020 SyGMa)</description>
              <displayCode>/Report Summary</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode>/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/23/49/341/1035</code>
        <title>bacteriology</title>
        <displayCode>/natural sciences/biological sciences/microbiology/bacteriology</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/155/48479582</code>
        <title>immunisation</title>
        <displayCode>/medical and health sciences/basic medicine/immunology/immunisation</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/159/653/1439</code>
        <title>vaccines</title>
        <displayCode>/medical and health sciences/basic medicine/pharmacology and pharmacy/pharmaceutical drugs/vaccines</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/155/643</code>
        <title>immunotherapy</title>
        <displayCode>/medical and health sciences/basic medicine/immunology/immunotherapy</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/159/649/1437</code>
        <title>antibiotic resistance</title>
        <displayCode>/medical and health sciences/basic medicine/pharmacology and pharmacy/drug resistance/antibiotic resistance</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode>/Digital agenda</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode>/Clean air</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode>/Artificial intelligence</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode>/Climate action</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode>/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages>en</availableLanguages>
        <code>/HORIZON-EIC-ACC-BF</code>
        <title>HORIZON EIC Accelerator Blended Finance</title>
        <description>HORIZON EIC Accelerator Blended Finance</description>
        <displayCode>/HORIZON EIC Accelerator Blended Finance</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode>/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>